Skip to main content
. 2016 Dec 7;4(1):ofw249. doi: 10.1093/ofid/ofw249

Table 1.

Procalcitonin Randomized Controlled Trials for Respiratory Tract Infections in Adult Patients

First Author (Year)
[Reference]
Trial Name
Setting
(Country)
Number and Type of Infection PCT Algorithm Exclusion Criteria Antibiotic Reduction Outcomes Clinical Outcomes
Christ-Crain (2004) [20] 1 hospital (Switzerland) 243 patients with LRTI Initiation only: antibiotics strongly discouraged (<0.1 µg/L), discouraged (0.1–0.25), encouraged (0.25–0.5), strongly encouraged (≥0.5). Repeat PCT after 6–24 hours if antibiotics withheld Severely immunocompromised, cystic fibrosis, active tuberculosis, hospital-acquired pneumonia 47% reduction in antibiotic use (P < .0001) No difference (including hospital mortality or long- term mortality at mean 5.3 months, hospital or ICU LOS, laboratory outcomes)
Christ-Crain (2006) [21]
ProCAP
1 hospital (Switzerland) 302 patients with CAP Initiation and Discontinuation: antibiotics strongly discouraged (<0.1 µg/L), discouraged (0.1–0.25), encouraged (0.25–0.5), strongly encouraged (≥0.5). Repeat PCT after 6–24 hours if antibiotics withheld, and at days 4, 6, and 8 Severely immunocompromised, cystic fibrosis, active tuberculosis, hospital-acquired pneumonia 52% relative risk of antibiotic exposure and median 5 vs 12 days of antibiotic treatment (P < .001 for both) No difference (including mortality, ICU admission, treatment success, laboratory outcomes)
Stolz
(2007) [22]
1 hospital (Switzerland) 208 patients with COPD exacerbation Initiation only: antibiotics discouraged (<0.1 µg/L), discouraged if clinically stable (0.1–0.25), encouraged (>0.25). Repeat PCT after 6–24 hours if antibiotics withheld Immunosuppression, asthma, cystic fibrosis, infiltrates on chest radiograph, psychiatric illness 56% relative risk of antibiotic exposure; 40% vs 72% overall antibiotic use (P < .0001 for both) No difference (including death, treatment success, hospital LOS, ICU admission, improvement in FEV1 at 14 days and 6 months, 6 month rehospitalization rate, mean time to next exacerbation)
Briel (2008) [25] 53 outpatient physicians in (Switzerland) 458 outpatients with acute respiratory tract infections Initiation and Discontinuation: antibiotics strongly discouraged (≤0.1 µg/L), discouraged (0.1–0.25), encouraged (>0.25). Repeat PCT after 6–24 hours if antibiotics withheld Antibiotics within prior 28 days, psychiatric disorders, severe immunosuppression, cystic fibrosis, active tuberculosis, need for immediate hospitalization 72% decrease in antibiotic use (95% CI, 66%–78%) No difference in activity restriction at 14 days, or ongoing symptoms or relapsing infection at 28 days
Kristoffersen (2009) [45] 3 hospitals (Denmark) 223 patients with LRTI Initiation only: antibiotics discouraged (<0.25 µg/L), encouraged (0.25–0.5), and strongly encouraged (≥0.5). Single PCT measurement None described Mean 5.1 vs 6.8 days of antibiotic therapy (P = .007) No difference (including hospital LOS, ICU admission, hospital mortality)
Schuetz (2009) [23]
ProHOSP
6 hospitals (Switzerland) 1359 patients with LRTI Initiation and Discontinuation: antibiotics strongly discouraged (≤0.1 µg/L), discouraged (0.1–0.25), encouraged (0.25–0.5), strongly encouraged (≥0.5). Repeat PCT after 6–24 hours if antibiotics withheld, and at days 3, 5, 7, and discharge Active intravenous drug use, severe immunosuppression, life-threatening comorbidities, hospital-acquired pneumonia, chronic infection requiring antibiotics Mean 5.7 vs 8.7 days of antibiotic therapy (relative change, −34.8%; 95% CI, −40.3% to −28.7%) No difference (composite of 30-day adverse outcomes including death, ICU admission, and disease-specific complications, and recurrent LRTI); less frequent antibiotic-associated adverse events (19.8% vs 28.1%)
Burkhardt (2010) [24] 15 primary care practices (Germany) 550 patients with mild respiratory tract infection Initiation only: no antibiotics (<0.25 µg/L) or yes antibiotics (≥0.25) Recent antibiotics, chronic liver disease, recent major surgery, autoimmune or systemic inflammatory disorders, dialysis, medullary C-cell carcinoma 21.5% vs 36.7% of patients received antibiotics No difference in significant health impairment after 14 days
Long
(2011) [46]
1 hospital (China) 172 patients with low- risk CAP (discharged from ED) Initiation only: antibiotics strongly discouraged (≤0.1 µg/L), discouraged (0.1–0.25), encouraged (>0.25). Repeat PCT after 6–12 hours if antibiotics withheld Pregnancy, antibiotics started ≥48 hours before enrollment, immunocompromised, withholding of life-support, active tuberculosis 55% relative risk of antibiotic exposure (P = .003); median 5 vs 7 days of antibiotic treatment (P < .001) No difference (all survived at 4 weeks, with similar clinical and laboratory outcomes)
Tang
(2013) [47]
1 hospital
(China)
225 patients with asthma exacerbation Initiation only: antibiotics strongly discouraged (≤0.1 µg/L), discouraged (0.1–0.25), encouraged (>0.25). Repeat PCT after 6–8 hours if initial PCT <0.25 Recent antibiotics, other bacterial infections, pneumonia on chest radiograph, other chronic respiratory disease, severe organ dysfunction 46.1% vs 74.8% of patients received antibiotics (P < .001) No difference (including asthma control, secondary ED visits, hospital readmission, additional steroids or antibiotics, FEV1)
Branche (2015) [48] 1 hospital (United States) 300 patients with nonpneumonic LRTI Initiation only: antibiotics strongly discouraged (≤0.1 µg/L), discouraged (0.1–0.25), encouraged (0.25–0.5), strongly encouraged (≥0.5). PCT intervention arm coupled with viral PCR testing. Definitive infiltrates on chest radiograph, immunosuppression, hypotension, ICU requirement, ≥15% peripheral bands, conditions known to increase PCT, antibiotics before admission No difference overall, but less antibiotics in algorithm-adherent patients (2.0 vs 4.0 days; P = .004) No difference in adverse events (no deaths in either arm; same median hospital LOS and number of posthospitalization healthcare visits)

Abbreviations: CAP, community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ED, emergency department; FEV1, forced expiratory volume at 1 second; ICU, intensive care unit; LOS, length of stay; LRTI, lower respiratory tract illness; PCR, polymerase chain reaction; PCT, procalcitonin.